COVID 19 Vaccine AstraZeneca

Disclaimer: The information on this page is intended for Vaccine Recipients only.

The Agency for Medicines and Medical Devices of Serbia (ALIMS) is on March 5, 2021. issued a conditional permit for the COVID-19 Vaccine AstraZeneca vaccine.
This medicine is under additional monitoring. This allows new security information to be discovered quickly. You can help by reporting any side effects you may have. For how to report side effects, see section 4 of the Package Leaflet, the ALIMS website or the text below this page.

Contact your healthcare provider for medical advice or treatment options. If you notice any side effects, you should inform your doctor, pharmacist or nurse.


AstraZeneca Reporting